Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Bigot

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1987
What biological specimen should be used for therapeutic cyclosporine monitoring?R Camsonne, M A Moulin, M Le Porrier, et al.
Therapie|January 1, 1986
[Thrombopenia caused by heparin. Evaluation of cases reported by the Caen-Basse-Normandie Drug Monitoring Center]X Troussard, B Mosquet, M C Bigot, et al.
Therapie|January 1, 1983
[Treatment of fetal tachyarrhythmia and the dosage of digoxin]M A Moulin, G Muller, P Letellier, et al.
Clinical Pharmacokinetics|June 1, 1990
Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysisD Debruyne, J P Ryckelynck, M Moulin, et al.
Journal of Chromatography|October 19, 1979
Gas chromatography-electron-impact and chemical-ionization mass spectrometry of haloperidol and its chlorinated homologueM A Moulin, R Camsonne, J P Davy, et al.
Psychopharmacology|January 1, 1982
Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patientsM A Moulin, J P Davy, D Debruyne, et al.
La Nouvelle Presse Medicale|October 16, 1982
[Chronic renal insufficiency. Elevated levels of the active metabolite (3-hydroxyquinidine) of quinidine]R Camsonne, M A Moulin, J P Ryckelynck, et al.
Presse Medicale (Paris, France : 1983)|September 10, 1988
[Crossed digitalis-alkaloid detoxication with an anti-digoxin antibody. Surveillance and mixed elimination of circulating digitoxin]R Camsonne, J C Potier, M A Moulin, et al.
Clinical Pharmacology and Therapeutics|November 1, 1985
Prilocaine in arthroscopy: clinical pharmacokinetics and rational useD Debruyne, M Moulin, C Thomassin, et al.
Therapie|March 1, 1981
[Practice of dose regimen adjustment for gentamicin by means of individual pharmacokinetic parameters (author's transl)]M A Moulin, R Camsonne, C Bazin, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1987
What biological specimen should be used for therapeutic cyclosporine monitoring?R Camsonne, M A Moulin, M Le Porrier, et al.
Therapie|January 1, 1986
[Thrombopenia caused by heparin. Evaluation of cases reported by the Caen-Basse-Normandie Drug Monitoring Center]X Troussard, B Mosquet, M C Bigot, et al.
Therapie|January 1, 1983
[Treatment of fetal tachyarrhythmia and the dosage of digoxin]M A Moulin, G Muller, P Letellier, et al.
Clinical Pharmacokinetics|June 1, 1990
Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysisD Debruyne, J P Ryckelynck, M Moulin, et al.
Journal of Chromatography|October 19, 1979
Gas chromatography-electron-impact and chemical-ionization mass spectrometry of haloperidol and its chlorinated homologueM A Moulin, R Camsonne, J P Davy, et al.
Psychopharmacology|January 1, 1982
Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patientsM A Moulin, J P Davy, D Debruyne, et al.
La Nouvelle Presse Medicale|October 16, 1982
[Chronic renal insufficiency. Elevated levels of the active metabolite (3-hydroxyquinidine) of quinidine]R Camsonne, M A Moulin, J P Ryckelynck, et al.
Presse Medicale (Paris, France : 1983)|September 10, 1988
[Crossed digitalis-alkaloid detoxication with an anti-digoxin antibody. Surveillance and mixed elimination of circulating digitoxin]R Camsonne, J C Potier, M A Moulin, et al.
Clinical Pharmacology and Therapeutics|November 1, 1985
Prilocaine in arthroscopy: clinical pharmacokinetics and rational useD Debruyne, M Moulin, C Thomassin, et al.
Therapie|March 1, 1981
[Practice of dose regimen adjustment for gentamicin by means of individual pharmacokinetic parameters (author's transl)]M A Moulin, R Camsonne, C Bazin, et al.
Pageof 4